特发性肺纤维化急性加重:国际调查与 harmonisation 呼吁
该国际调查由专家小组设计,邀请具 ILD 专长的呼吸科医生参与,评估 AE-IPF 预防、诊断和治疗策略的全球差异。509 名来自 66 个国家的呼吸科医生回应,发现各地管理方法存在显著地理差异,亟需全球试验和指南改善预后。
要点
- AE-IPF 预防措施常用抗纤维化药物和疫苗接种
- 94% responders 使用高剂量类固醇,其他免疫抑制策略差异大
- 67% 在 AE-IPF 期间启动抗纤维化治疗,有创通气/ECMO 主要作为移植桥接
核心结论
- AE-IPF 的预防、诊断和治疗方法在全球范围内存在差异,需要全球试验和指南来改善预后。
研究设计与样本
- 国际专家小组设计问卷调查,邀请具 ILD 专长的呼吸科医生参与,共 509 名来自 66 个国家的呼吸科医生回应。
主要发现
- 常见预防措施包括抗纤维化药物和疫苗接种;诊断差异最显著在使用 Krebs von den Lungen-6 和病毒检测,而高分辨率计算机断层扫描、脑钠肽和 D-二聚体普遍应用。
- 高剂量类固醇广泛使用(94%);其他免疫抑制剂和治疗策略差异很大;仅 4% 回应者从不使用免疫抑制;67% 在 AE-IPF 期间启动抗纤维化治疗。
- 有创通气或体外膜氧合主要用作移植桥接;82% 医生全面教育患者 AE-IPF 的严重性,64% 考虑姑息治疗。
关键数值与推荐
- 高剂量类固醇使用率 94%;从不使用免疫抑制的回应者仅 4%;AE-IPF 期间启动抗纤维化治疗者 67%;全面教育患者严重性者 82%;考虑姑息治疗者 64%。
临床怎么用
- 临床医生应了解 AE-IPF 管理存在全球差异,高剂量类固醇广泛使用但其他免疫抑制策略不一,抗纤维化治疗可在 AE-IPF 期间启动,有创通气/ECMO 作为移植桥接,并重视患者教育和姑息治疗。
局限性
- 调查基于自愿回应,可能不代表所有呼吸科医生的实践;未报告回应率或样本代表性限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is an often deadly complication of IPF. No focussed international guidelines for the management of AE-IPF exist. The aim of this international survey was to assess the global variability in prevention, diagnostic and treatment strategies for AE-IPF.Pulmonologists with ILD expertise were invited to participate in a survey designed by an international expert panel.509 pulmonologists from 66 countries responded. Significant geographical variability in approaches to manage AE-IPF was found. Common preventive measures included antifibrotic drugs and vaccination. Diagnostic differences were most pronounced regarding use of Krebs von den Lungen-6 and viral testing, while high-resolution computed tomography, brain natriuretic peptide and D-dimer are generally applied. High-dose steroids are widely administered (94%); the use of other immunosuppressant and treatment strategies is highly variable. Very few (4%) responders never use immunosuppression. Antifibrotic treatments are initiated during AE-IPF by 67%. Invasive ventilation or extracorporeal membrane oxygenation are mainly used as a bridge to transplantation. Most physicians educate patients comprehensively on the severity of AE-IPF (82%) and consider palliative care (64%).Approaches to the prevention, diagnosis and treatment of AE-IPF vary worldwide. Global trials and guidelines to improve the prognosis of AE-IPF are needed.
引用
- Kreuter M, Polke M, Walsh SLF, et al. Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation. Eur Respir J. 2020. PMID: 32060068. doi:10.1183/13993003.01760-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。